Artelo Biosciences, Inc. (ARTL) Tops Q3 EPS by 44c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q3 EPS of ($0.35), $0.44 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Invesco Mortgage Capital declares $0.12 monthly dividend for June 2026
• Nutrien warns shareholders about below-market mini-tender offer